Arrowhead Pharmaceuticals, Inc. (ARWR)
84.91
-3.68
(-4.15%)
USD |
NASDAQ |
Aug 28, 16:00
84.93
+0.02
(+0.02%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Cash and Short Term Investments (Quarterly) : 1.602B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.602B |
| March 31, 2026 | 1.784B |
| December 31, 2025 | 916.61M |
| September 30, 2025 | 919.37M |
| June 30, 2025 | 900.37M |
| March 31, 2025 | 1.097B |
| December 31, 2024 | 552.94M |
| September 30, 2024 | 680.96M |
| June 30, 2024 | 436.67M |
| March 31, 2024 | 523.11M |
| December 31, 2023 | 220.28M |
| September 30, 2023 | 403.63M |
| June 30, 2023 | 451.70M |
| March 31, 2023 | 481.00M |
| December 31, 2022 | 501.83M |
| September 30, 2022 | 376.40M |
| June 30, 2022 | 416.50M |
| March 31, 2022 | 401.90M |
| December 31, 2021 | 330.13M |
| September 30, 2021 | 367.79M |
| June 30, 2021 | 516.31M |
| March 31, 2021 | 577.32M |
| December 31, 2020 | 305.33M |
| September 30, 2020 | 315.49M |
| June 30, 2020 | 287.03M |
| Date | Value |
|---|---|
| March 31, 2020 | 307.61M |
| December 31, 2019 | 502.00M |
| September 30, 2019 | 258.70M |
| June 30, 2019 | 237.90M |
| March 31, 2019 | 218.20M |
| December 31, 2018 | 243.75M |
| September 30, 2018 | 76.53M |
| June 30, 2018 | 60.48M |
| March 31, 2018 | 91.54M |
| December 31, 2017 | 50.70M |
| September 30, 2017 | 65.61M |
| June 30, 2017 | 75.14M |
| March 31, 2017 | 86.63M |
| December 31, 2016 | 102.11M |
| September 30, 2016 | 85.37M |
| June 30, 2016 | 44.65M |
| March 31, 2016 | 61.46M |
| December 31, 2015 | 76.60M |
| September 30, 2015 | 98.75M |
| June 30, 2015 | 110.53M |
| March 31, 2015 | 116.01M |
| December 31, 2014 | 127.52M |
| September 30, 2014 | 154.16M |
| June 30, 2014 | 162.18M |
| March 31, 2014 | 160.65M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 788.49M |
| Revolution Medicines, Inc. | 3.938B |
| Moderna, Inc. | 5.138B |
| Intellia Therapeutics, Inc. | 437.76M |
| Denali Therapeutics, Inc. | 710.47M |